Branding - Clinical Research Informer

How brands can tap into wellness – lessons from influencers

Bio Pharma Dive

NOVEMBER 21, 2022

Our latest research uncovers new insights on how brands can truly close the wellness gap and grow within their industry sectors.

Branding

Branding Research

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

DECEMBER 12, 2024

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. Branded drugs, developed through extensive research and clinical trials, often enjoy patent protection for a limited period.

Branding

Branding Licensing Licensing Drugs

ASH23: Pharma branding, Editas’ high bar and clinical trial diversity

Bio Pharma Dive

DECEMBER 11, 2023

Editas had the tall task Monday of convincing ASH attendees its gene therapy for sickle cell disease could improve on Casgevy and Lyfgenia.

Clinical Trials

Clinical Trials Clinical Trials Branding Gene Therapy

Pharmaceutical OTC brands are being outcompeted by private-label OTC brands in retail and e-commerce marketplaces

Bio Pharma Dive

FEBRUARY 28, 2022

Self-care and the resulting increased use of over-the-counter (OTC) medications is a growing global trend.

Branding

Industry hails mandatory QR code on top 300 drug brands from Aug 1, 2023

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 22, 2022

Drug manufacturers have hailed the Drugs (Eighth Amendment) Rules, 2022 mandating barcode or quick response (QR) code on the label of top 300 brands of formulations from August 1, 2023, saying that QR codes will help identify misbranded or counterfeit medicines as well as recall the products if its quality gets compromised during manufacturing.

Branding

Branding Drugs Manufacturing Medicine

Marketing Strategies for Pharma Brands: Driving HCP Engagement

Pharma Marketing Network

MARCH 17, 2025

But how can pharma brands stand out in a crowded market? Traditional marketing channels, such as in-person sales reps, remain relevant, but digital transformation has shifted the way HCPs interact with medical information and brand messaging. Key Marketing Strategies for Pharma Brands to Reach HCPs 1.

Branding

Branding Marketing Compliance Pharma Companies

Sanofi unveils global health brand for medicines supply

Pharmaceutical Technology

JULY 5, 2022

Sanofi has unveiled the global health brand, Impact, to make available standard of care treatments for non-profit supply to at-risk populations in low-income countries. The introduction of the Impact brand is one of the steps adopted since the formation of Sanofi Global Health last year.

Branding

Branding Medicine Insulin Antibody

Upscaling your brand strategy: New ways of planning

pharmaphorum

JUNE 17, 2024

Learn how to upscale your brand strategy with new and innovative ways of planning. Discover effective brand planning strategies to take your brand to the next level.

Branding

Amazon bundles its telehealth services under one brand

pharmaphorum

JUNE 28, 2024

Amazon’s strategy in telehealth has coalesced around a pay-per-visit and subscription-based model under a new brand – Amazon One Medical.

Branding

Maximizing ROI with Branded Generics: A Comprehensive Guide

Drug Patent Watch

JUNE 18, 2024

Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same active ingredients as their brand-name counterparts but are typically sold at a lower price point.

Branding

Branding Generic Drugs Containment Manufacturing

A year with COVID-19: The impact of data on pharma marketing

Bio Pharma Dive

MARCH 29, 2021

Learn how three pharma brands used data to validate and adjust their promotional spend in 2020.

Branding

Branding Marketing

At least three oncology 2023 brand launches have blockbuster potential

Pharmaceutical Technology

JANUARY 22, 2024

An analysis of GlobalData’s analyst consensus sales and forecast database reveals that three out of 12 novel oncology brands that launched globally from November 2022 to December 2023 have the potential to reach blockbuster sales.

Branding

Branding Sales

J&J, world's largest drugmaker, plans to split in two

Bio Pharma Dive

NOVEMBER 12, 2021

The industry giant and mainstay of corporate America will separate its consumer health business from its drug and medical device units, which will retain the J&J brand.

Branding

Branding Drugs

Lilly wins FDA approval of new kind of diabetes drug

Bio Pharma Dive

MAY 13, 2022

Tirzepatide, now branded as Mounjaro, helped improve blood sugar control in testing and has been shown to have powerful weight loss effects as well, making it one of the most closely watched drugs in Lilly's pipeline.

FDA Approval

FDA Approval Drugs Branding

SEC recommends approval for MSN Laboratories’ sleep disorder drug

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 14, 2024

The drug is a generic form of US-based Harmony Biosciences’ brand Wakix, a first-in-class […]

Drugs

Drugs Clinical Trials Clinical Trials Branding

Why a healthy search strategy can power pharma brand growth

pharmaphorum

DECEMBER 19, 2024

Discover how implementing a healthy and effective search strategy, focusing on Google, can significantly boost growth and success for pharmaceutical brands.

Branding

2025 Brand Drug Challenges: A GoodRx Perspective

Drug Channels

JANUARY 17, 2025

She then describes how GoodRx's Cash Point-of-Sale Solution can help brands improve gross-to-net (GTN) while also making medications more affordable for patients. Todays guest post is from Dorothy Gemmell, Chief Commercial Officer and President, Manufacturer Solutions, at GoodRx. Dorothy highlights five trends to watch in 2025.

Branding

Branding Drugs Sales Manufacturing

Diabetes advocacy group discourages use of compounded GLP-1 drugs

Bio Pharma Dive

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Pharmacy

Pharmacy Doctor Doctors Drugs

How to ensure brand planning success for 2024

pharmaphorum

FEBRUARY 6, 2024

Daniel Kohlstaedt, managing director at PurpleLeaf Strategy, discusses how new technologies can help pharmaceutical leaders plan for success during their upcoming brand planning cycle.

Branding

FDA approves new CAR-T competitor to Gilead’s Tecartus

Bio Pharma Dive

NOVEMBER 11, 2024

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the brand name Aucatzyl.

FDA Approval

FDA Approval Branding Development

How pharma digital marketing can excel

World of DTC Marketing

AUGUST 9, 2020

This team of consultants would ideally be made up of people who not only have expertise in digital marketing but who also can ensure that a brand team’s digital strategy is aligned with online health seekers. Right now a lot of brands, both inside and outside of pharma, are flying blind when it comes to digital.

Marketing

Marketing Branding Development

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease

Pharmaceutical Technology

JULY 2, 2024

Leqembi will now face a challenger as donanemab enters the market under the brand name Kisunla.

FDA Approval

FDA Approval Branding Marketing

Sanofi, expanding in radiopharma, strikes a joint venture deal

Bio Pharma Dive

OCTOBER 17, 2024

The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand.

Branding

Branding Development

Lilly weight loss drug approved by FDA

Bio Pharma Dive

NOVEMBER 8, 2023

The pharmaceutical company will sell the GLP-1 drug, branded as Zepbound, at a list price about 20% lower than Novo Nordisk's competing drug Wegovy.

Drugs

Drugs Branding

Pharma to raise prices on more than 250 drugs in the US from January 2025

Pharmaceutical Technology

JANUARY 14, 2025

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

Pharma Companies

Pharma Companies Branding Drugs Marketing

STAT+: ‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J

STAT News

APRIL 4, 2023

Until now, the company has focused on selling generic versions of brand-name medicines. But in a tweet yesterday, the upstart announced that it is selling the Invokana and Invokamet diabetes drugs from Janssen, a unit at Johnson & Johnson.

Branding

Branding Medicine Manufacturing Drugs

A five-step approach for optimising established brands' portfolio value

pharmaphorum

JANUARY 3, 2025

A five-step approach for optimising established brands' portfolio value Nicole.Raleigh Fri, 03/01/2025 - 12:00 Bookmark this

Branding

Novo Nordisk follows Lilly in sharply cutting price of insulin drugs

Bio Pharma Dive

MARCH 14, 2023

Responding to policy changes and pressure over high drug costs, the pharma is reducing the sticker price of four branded diabetes medicines by up to 75%.

Insulin

Insulin Drugs Branding Medicine

How to choose the right digital agency

World of DTC Marketing

JULY 30, 2021

Ensuring you have hired the right one is essential to your brand’s success on both the HCP and consumers’ sides. Many CPG brands are bringing their digital marketing and media buying in-house to reduce costs and ensure that the digital strategies are aligned with key brand insights. This was a huge benefit for us.

Branding

Branding Pharma Companies Development Marketing

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

APRIL 12, 2024

To learn more about enhancing patient engagement and adherence, download CareMetx's new report: Driving Brand Success: Minimize Risk and Capture Missed Value from Patient Engagement and Adherence. She then outlines how manufacturers can build adherence into their patient services program to increase patient engagement.

Branding

Branding Manufacturing Drugs

Drug price hikes moderate as rebates rise, report finds

Bio Pharma Dive

APRIL 21, 2022

List prices for branded medicines rose by nearly 5% last year, according to IQVIA, a figure that fell to 1% after accounting for rebates and discounts.

Branding

Branding Medicine Drugs

Why pharma should invest in evidence-based physician education

Bio Pharma Dive

AUGUST 5, 2024

For years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. With the advent of precision medicine, however, ongoing disease state education has become increasingly critical.

Branding

Branding Manufacturing Medicine Marketing

EQRx builds cancer drug pipeline as plans to challenge big pharma take shape

Bio Pharma Dive

OCTOBER 27, 2020

The startup, which aims to develop lower-cost alternatives to branded medicines, has licensed two drugs from CStone Pharmaceuticals in a deal that could signal a coming price war in cancer immunotherapy.

Licensing

Licensing Licensing Drugs Branding

Signal: Pharma giant Novartis to spin-off generics brand

Pharmaceutical Technology

SEPTEMBER 6, 2023

Sandoz, the generics division of Novartis, has underperformed in recent years, but the spin-off may not settle investors.

Branding

This Drug Shows Potential to Stop Migraines Before They Begin

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 16, 2024

Sold under the brand name Ubrelvy, ubrogepant is already used to treat migraines, but researchers in the US wanted to […]

Drugs

Drugs Branding Research Clinical Trials

Imitation Ozempic Is Flooding The Market: Here’s What You Need to Know

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 15, 2024

(Abdullah Durmaz/Getty Images) In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.

Marketing

Marketing Branding Drugs Clinical Trials

SXSW 2024 Insights: Why the Greatest Risk a Brand Can Take Is Being Ordinary, Part 1

Intouch Solutions

MARCH 13, 2024

Our team is on the ground at SXSW 2024, and as we navigate through the bustling streets of downtown Austin, Texas — where the magic of immersive brand experiences dress the streets — we can’t help but feel the pulse of innovation surrounding us. Contact us to learn how you can ensure your brand is staying ahead of the curve.

Branding

Branding Marketing

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

Pharma Mirror

MAY 19, 2021

From 14th February 2021, Rashedi Hassan focuses his responsibility on developing extensive marketing and sales plan to strengthen the Telstar brand position in the local pharmaceutical market and to promote the presence and distribution of Telstar branded Life Sciences service & product solutions in the region, particularly in the field of engineering (..)

Sales

Sales Marketing Engineer Life Science

J&J grows cancer drug portfolio with newly approved bispecific

Bio Pharma Dive

AUGUST 10, 2023

The drug, which will be sold under the brand name Talvey, is now cleared by the FDA to treat multiple myeloma, a blood cancer that J&J has identified as a research priority.

Drugs

Drugs Branding Research

Pfizer pledges not-for-profit sale of medicines in low-income countries

Bio Pharma Dive

MAY 25, 2022

The new initiative commits Pfizer to supplying current and future branded medicines at lower cost to 45 countries. The pharma has been criticized for not doing enough to make its COVID-19 vaccine and pill available globally.

Medicine

Medicine Sales Branding Vaccination

Dear FDA: WTF?

World of DTC Marketing

MARCH 18, 2021

SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. A brand name is only as effective, or ineffective, as the messaging and brand experience that goes with it. In other words, they resonate.

Branding

Branding Pharma Companies Pharma Production Drugs

The Most Common Pain Relief Drug in The World Induces Risky Behavior, Study Shows

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 17, 2022

Acetaminophen, also known as paracetamol and sold widely under the brand names Tylenol and Panadol, also increases risk-taking, according to a study from 2020 […]. One of the most consumed drugs in the US – and the most commonly taken analgesic worldwide – could do a lot more than simply take the edge off your headache.

Drugs

Drugs Branding Clinical Trials Clinical Trials

Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. The forecast branded NHS drug sales growth figure for 2023 was adjusted to 5.63%. The UK government’s decision to set an unprecedented payback rate of 26.5%

Sales

Sales Branding Drugs Medicine

10 things DTC marketers should focus on in 2021

World of DTC Marketing

JANUARY 4, 2021

The age of social media has proved that people like to share experiences around brands. 7even : Every brand team should have an integrated digital marketing person. They should not rely on a “digital team” who meets with the brand to launch digital initiatives. 10en : Expect the media to be hostile towards pharma.

Marketing

Marketing Branding Engineer Doctors

How brands can tap into wellness – lessons from influencers

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Trending Sources

ASH23: Pharma branding, Editas’ high bar and clinical trial diversity

Pharmaceutical OTC brands are being outcompeted by private-label OTC brands in retail and e-commerce marketplaces

Industry hails mandatory QR code on top 300 drug brands from Aug 1, 2023

Marketing Strategies for Pharma Brands: Driving HCP Engagement

Sanofi unveils global health brand for medicines supply

Upscaling your brand strategy: New ways of planning

Amazon bundles its telehealth services under one brand

Maximizing ROI with Branded Generics: A Comprehensive Guide

A year with COVID-19: The impact of data on pharma marketing

At least three oncology 2023 brand launches have blockbuster potential

J&J, world's largest drugmaker, plans to split in two

Lilly wins FDA approval of new kind of diabetes drug

SEC recommends approval for MSN Laboratories’ sleep disorder drug

Why a healthy search strategy can power pharma brand growth

2025 Brand Drug Challenges: A GoodRx Perspective

Diabetes advocacy group discourages use of compounded GLP-1 drugs

How to ensure brand planning success for 2024

FDA approves new CAR-T competitor to Gilead’s Tecartus

How pharma digital marketing can excel

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease

Sanofi, expanding in radiopharma, strikes a joint venture deal

Lilly weight loss drug approved by FDA

Pharma to raise prices on more than 250 drugs in the US from January 2025

STAT+: ‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J

A five-step approach for optimising established brands' portfolio value

Novo Nordisk follows Lilly in sharply cutting price of insulin drugs

How to choose the right digital agency

How Patient Engagement Can Reduce Brand Launch Risks

Drug price hikes moderate as rebates rise, report finds

Why pharma should invest in evidence-based physician education

EQRx builds cancer drug pipeline as plans to challenge big pharma take shape

Signal: Pharma giant Novartis to spin-off generics brand

This Drug Shows Potential to Stop Migraines Before They Begin

Imitation Ozempic Is Flooding The Market: Here’s What You Need to Know

SXSW 2024 Insights: Why the Greatest Risk a Brand Can Take Is Being Ordinary, Part 1

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

J&J grows cancer drug portfolio with newly approved bispecific

Pfizer pledges not-for-profit sale of medicines in low-income countries

Dear FDA: WTF?

The Most Common Pain Relief Drug in The World Induces Risky Behavior, Study Shows

Pharma sector reels as UK Government doubles VPAS payback rate on NHS drugs

10 things DTC marketers should focus on in 2021

Stay Connected